Loading...
Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study
PURPOSE: To evaluate the 1-year safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease compared with placebo. METHODS: SONATA (Safety Of a 5.0% coNcentrATion of lifitegrAst ophthalmic solution) was a multicenter, randomized, prospective, double-masked, placebo-controlled pha...
Na minha lista:
| Udgivet i: | Cornea |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cornea
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4859202/ https://ncbi.nlm.nih.gov/pubmed/27055211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ICO.0000000000000803 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|